457 results on '"Comai, Stefano"'
Search Results
52. The novel uncompetitive NMDA receptor antagonist esmethadone (REL-1017) has no meaningful abuse potential in recreational drug users.
53. Psychopathological and sociodemographic features in treatment-resistant unipolar depression versus bipolar depression: a comparative study
54. Serum Tryptophan And 5-Hydroxytryptophan At Birth And During Post-Partum Days
55. Anxiolytic effects of the melatonin MT2 receptor partial agonist UCM765: Comparison with melatonin and diazepam
56. Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome.
57. Is Poor Lithium Response in Individuals with Bipolar Disorder Associated with Increased Degradation of Tryptophan along the Kynurenine Pathway? Results of an Exploratory Study
58. Melatonin and aggressive behavior: A systematic review of the literature on preclinical and clinical evidence
59. Sex Differences in Responses to Antidepressant Augmentations in Treatment-Resistant Depression
60. Acute and Chronic Pain Preclinical Models to Study the Analgesic Properties of Melatonergic Compounds
61. Photothrombotic Mouse Models for the Study of Melatonin as a Therapeutic Tool After Ischemic Stroke
62. Distinct Effects of Antidepressants in Association With Mood Stabilizers and/or Antipsychotics in Unipolar and Bipolar Depression
63. Tryptophan Metabolites, Cytokines, and Fatty Acid Binding Protein 2 in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
64. CCNP Award Paper: Unveiling the role of melatonin [MT.sub.2] receptors in sleep, anxiety and other neuropsychiatric diseases: a novel target in psychopharmacology
65. Centella asiatica (L.) urban from Nepal: Quali-quantitative analysis of samples from several sites, and selection of high terpene containing populations for cultivation
66. Antinociceptive properties of selective MT2 melatonin receptor partial agonists
67. Early Dysfunction of Substantia Nigra Dopamine Neurons in the ParkinQ311X Mouse
68. A DROSOPHILA APPROACH TO STUDY THE EFFECTS OF ATYPICAL ANTIPSYCHOTIC DRUGS
69. Dysfunction of the serotonergic system in the brain of synapsin triple knockout mice is associated with behavioral abnormalities resembling synapsin-related human pathologies
70. Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice
71. Protein and non-protein (free and protein-bound) tryptophan in legume seeds
72. The content of proteic and nonproteic (free and protein-bound) tryptophan in quinoa and cereal flours
73. Composition of Cacao Beans
74. Sleep-wake characterization of double MT1/MT2 receptor knockout mice and comparison with MT1 and MT2 receptor knockout mice
75. Quinoa: Protein and Nonprotein Tryptophan in Comparison with Other Cereal and Legume Flours and Bread
76. List of Contributors
77. Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C
78. Franco Fraschini, MD, PhD (1932‐2020)
79. Melatonin recovers sleep phase delayed by MK‐801 through the melatonin MT 2 receptor‐ Ca 2+ ‐CaMKII‐CREB pathway in the ventrolateral preoptic nucleus
80. Transcranial direct current stimulation of the mouse prefrontal cortex modulates serotonergic neural activity of the dorsal raphe nucleus
81. Dysfunction of serotonergic activity and emotional responses across the light‐dark cycle in mice lacking melatonin MT 2 receptors
82. Ventricular cerebrospinal fluid melatonin concentrations investigated with an endoscopic technique
83. A Study of Tryptophan Metabolism via Serotonin in Ventricular Cerebrospinal Fluid in HIV-1 Infection Using a Neuroendoscopic Technique
84. Cloricromene effect on the enzyme activities of the tryptophan–nicotinic acid pathway in diabetic/hyperlipidemic rabbits
85. Melatonin MT1 receptor as a novel target in neuropsychopharmacology: MT1 ligands, pathophysiological and therapeutic implications, and perspectives
86. Melatonin MT1 and MT2 Receptors Exhibit Distinct Effects in the Modulation of Body Temperature across the Light/Dark Cycle
87. Differential Function of Melatonin MT1 and MT2 Receptors in REM and NREM Sleep
88. Sleep well. Untangling the role of melatonin MT1 and MT2 receptors in sleep
89. Investigation of the Relationship among Cortisol, Pro-inflammatory Cytokines, and the Degradation of Tryptophan into Kynurenine in Patients with Major Depression and Suicidal Behavior
90. Melatonin recovers sleep phase delayed by MK‐801 through the melatonin MT2 receptor‐ Ca2+‐CaMKII‐CREB pathway in the ventrolateral preoptic nucleus.
91. Dysfunction of serotonergic activity and emotional responses across the light‐dark cycle in mice lacking melatonin MT2 receptors.
92. Reduced peripheral availability of tryptophan and increased activation of the kynurenine pathway and cortisol correlate with major depression and suicide.
93. Targeting Melatonin MT2 Receptors: A Novel Pharmacological Avenue for Inflammatory and Neuropathic Pain
94. Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain
95. High frequency stimulation of the anterior vermis modulates behavioural response to chronic stress: involvement of the prefrontal cortex and dorsal raphe?
96. Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E
97. Reduced peripheral availability of tryptophan and increased activation of the kynurenine pathway and cortisol correlate with major depression and suicide
98. Drugs for Insomnia beyond Benzodiazepines: Pharmacology, Clinical Applications, and Discovery
99. Novel selective melatonin MT2 receptor agonist in the treatment of insomnia
100. Distinct role of melatonin MT1 and MT2 receptors in sleep and anxiety: insights from melatonin receptor knockout mice
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.